2024 Conference on Lasers and Electro-Optics, CLEO 2024, North Carolina, Amerika Birleşik Devletleri, 7 - 10 Mayıs 2024, (Tam Metin Bildiri)
We present an automated, deep learning-based method for HER2 score classification in breast cancer, achieving 85.47% accuracy on tissue microarrays from 300 patients. This method can significantly improve the HER2 evaluation process, saving diagnostician time.